#antibiotic-resistance

#antibiotic-resistance

Rising cases of invasive group A strep infections in the U.S. indicate increasing health risks and antibiotic resistance.

Researchers are exploring non-antibiotic methods to prevent recurrent UTIs, including vaccines and non-antibiotic drugs.

Phage therapy demonstrates potential as a solution to antibiotic resistance in bacterial infections.

Microbes may travel long distances on high-level winds, highlighting the risk of antibiotic resistance spreading across regions.

Abstaining from sex is the only way to completely avoid STIs, as antibiotics are becoming increasingly ineffective against infections like gonorrhea.

The human microbiome may harbor untapped reservoirs of antibiotic resistance genes, posing risks for public health and superbug threats.

Cholera strains in travelers highlight risks of antibiotic resistance and emphasizes the need for awareness and improved sanitation measures in low-income countries.

A new molecule, lariocidin, discovered from soil samples shows promise in treating antibiotic-resistant e. coli infections.

Locus's phage therapy effectively targets and degrades E. coli bacteria, showing promising results in treating urinary tract infections (UTIs).

Antibiotic persistence allows bacterial survival under stress, complicating treatment strategies.

The Longitude Prize has been awarded for a rapid infection test to combat superbugs.

The fight against superbugs involves delaying antibiotic resistance by using treatments judiciously and investing in prevention measures and new vaccines.